(NP (NP (JJ Transcriptional) (NN regulation)) (PP (IN of) (NP (NP (NP (NN interleukin) (CD 3)) (PRN (-LRB- -LRB-) (NP (NN IL3)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ primary) (JJ human) (NN T) (NNS lymphocytes))))) (. .))
(NP (NP (NN Role)) (PP (IN of) (NP (ADJP-COOD (ADJP (NP (NN AP-1-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ octamer-binding))) (NNS proteins))) (PP (IN in) (NP (NP (NN control)) (PP (IN of) (NP (NN IL3) (NN gene) (NN expression))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN investigated) (NP (NP (DT the) (ADJP-COOD (ADJP (JJ molecular)) (CC and) (ADJP (JJ biochemical))) (NN basis)) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NN interleukin) (CD 3)) (PRN (-LRB- -LRB-) (NP (NN IL3)) (-RRB- -RRB-))) (NN gene) (NN expression)) (PP (IN in) (NP (JJ primary) (JJ human) (NN T) (NNS lymphocytes))))) (PP-TMP (VBG following) (NP (NP (NP-COOD (NP (NN CD3)) (CC and) (NP (NN CD2))) (NN receptor) (NP-COOD (NP (NN stimulation)) (CC or) (NP (NN activation)))) (PP (IN by) (NP-COOD (NP (NN phytohemagglutinin)) (CC plus) (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate))))))))))) (. .))
(S (S (NP-SBJ (-NONE- *-46)) (VP (VBG Using) (NP (NP (NP-COOD (NP (NN transfection)) (CC and) (NP (NN reporter) (NN gene))) (NNS assays)) (VP (ADVP (RB specifically)) (VBN designed) (NP (-NONE- *)) (PP (IN for) (NP (JJ primary) (NN T) (NNS lymphocytes))) (PP (IN in) (NN conjunction) (IN with) (NP-COOD (NP (NN gel) (NN retardation) (NNS assays)) (, ,) (NP (NN Western) (NN blot) (NNS analyses)) (CC and) (NP (NN UV) (JJ cross-linking) (NNS studies)))))))) (, ,) (NP-SBJ-46 (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (UCP-COOD (NP (NN c-Jun)) (, ,) (NP (NN c-Fos)) (, ,) (CC and) (ADJP (NN octamer-binding))) (NNS proteins)) (VP (VBP play) (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (NP (JJ transcriptional) (NN activation)) (PP (IN of) (NP (DT the) (NN IL3) (NN gene))))) (PP (IN via) (NP (NP (PRP$ their) (NN interaction)) (PP (IN with) (NP (NP (CD two) (JJ specific) (NNS regions)) (VP (VBN contained) (NP (-NONE- *)) (PP (IN within) (NP (DT the) (NN IL3) (JJ 5'-flanking) (NN sequence)))))))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP-SBJ (NP (DT the) (NN region)) (PP (IN between) (NP (NP (NNS bases) (NP-COOD (NP (CD -107)) (CC and) (NP (CD -59)))) (PP (IN of) (NP (NP (DT the) (NN IL3) (NN promoter)) (VP (VBG containing) (NP (JJ putative) (NP-COOD (NP (NN AP-2)) (CC and) (NP (NN Sp1))) (NN binding) (NNS motifs)))))))) (VP (VBZ appears) (ADJP-PRD (JJ necessary) (PP (IN for) (NP (NP (JJ basal) (NN level) (NN expression)) (PP (IN of) (NP (DT the) (NN IL3) (NN gene))))))) (. .))
(S (NP-SBJ (DT The) (NNS data)) (ADVP (RB also)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ-COOD (NP (NN CD2) (NN receptor) (NN activation)) (CC and) (NP (NP-COOD (NP (NN phytohemagglutinin)) (CC plus) (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate))) (NN stimulation))) (VP (VBP augment) (NP (NN T) (NN cell) (NN IL3) (NN gene) (NN expression)) (PP (IN through) (NP (DT the) (JJ same) (ADJP-COOD (ADJP (NP (JJ cis-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ trans-activating))) (NNS signals))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (MD should) (VP (VB contribute) (PP (TO to) (NP (NP (DT a) (JJR better) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN IL3) (NN gene) (NN expression)) (PP (IN in) (NP (JJ human) (NN T) (NNS lymphocytes))))))))))) (. .))
